Clinical study of camrelizumab combined with docetaxel and carboplatin in neoadjuvant treatment of locally advanced oesophageal squamous cell carcinoma
第一作者机构：[1]Hebei Med Univ, Dept Thorac Surg, Hosp 4, North Gate, Shijiazhuang, Hebei, Peoples R China
推荐引用方式(GB/T 7714)：
Wang R.,Zhang G.,Zhu Q.,et al.Clinical study of camrelizumab combined with docetaxel and carboplatin in neoadjuvant treatment of locally advanced oesophageal squamous cell carcinoma[J].ANNALS OF ONCOLOGY.2023,34:S866-S866.doi:10.1016/j.annonc.2023.09.1455.
APA：
Wang, R.,Zhang, G.,Zhu, Q.,Ma, T.,Weng, C....&Mi, L..(2023).Clinical study of camrelizumab combined with docetaxel and carboplatin in neoadjuvant treatment of locally advanced oesophageal squamous cell carcinoma.ANNALS OF ONCOLOGY,34,
MLA：
Wang, R.,et al."Clinical study of camrelizumab combined with docetaxel and carboplatin in neoadjuvant treatment of locally advanced oesophageal squamous cell carcinoma".ANNALS OF ONCOLOGY 34.(2023):S866-S866
医学